1. World Health Organization. Adherence to long-term therapies: evidence for action. WHO Library Cataloguing-in-Publication Data, Geneva, WHO 2003; 211 рр.
2. Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a metaanalysis of prevalence and clinical consequences. Eur Heart J 2013; 34: 2940-8.
3. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence. Its importance in cardiovascular outcomes. Curculation 2009; 119: 3028-35.
4. Van Dulmen S, Sluijs E, van Dijk L, et al. Patient adherence to medical treatment: a review of reviews. BMC Health Service Research, 2007; 7: 55.
5. Pruijm M, Schneider M-P, Burnier M. Patient adherence and the pharmacological treatment of arterial hypertension. ESH scientific letter, 2010; 11 (7) available at www.viamedical.pl
6. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence terminology and definition. Value in Health, 2008, 11(1): 44-7.
7. Martsevich SY Navasardyan AR, Kutishenko NP, et al. The assessment of compliance to the use of new oral anticoagulants in patients with atrial fibrillation according to the PROFILE register. Rational Pharmacotherapy in Cardiology 2014; 10(6): 62530. Russian (Марцевич С. Ю., Навасардян А. Р., Кутишенко Н. П., Захарова А. В. Оценка приверженности к приему новых оральных антикоагулянтов у пациентов с фибрилляцией предсердий по данным регистра ПРОФИЛЬ. РФК 2014; 10(6): 625-30).
8. Laufs U, Retting-Ewen V, Bohm M. Strategies to improve drug adherence. Eur Heart J 2011; 32: 264-8.
9. Levina IL. On the term "adherence (to) treatment". Bulletin of the Kuzbass scientific centre. 2013; 17: 51-3. Russian (Левина И. Л. О понятии "приверженность (к) лечению". Вестник Кузбасского научного центра 2013; 17: 51-3).
10. Garner JB. Problems of nonadherence in cardiology and proposals to improve outcomes. Am J Cardiol 2010; 105: 1495-501.
11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-97.
12. Eisenberger U, Wuthrich RP, Bock A, et al. Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants. Transplantation 2013; 96(3): 245-50.
13. Warren JR, Falster MO, Fox D, et al. Factors influencing adherence in long-term use of statin. Farmacoepidemiology and drug safety. 2013 Published online: willeyonlinelibrary.com DOI: 10.1002/pds.3526
14. Khokhlov AL, Lisenkova LA, Rakov AA. Analysis of the determinants of adherence to antihypertensive therapy. Good clinical practice 2003; (4): 59-66. Russian (Хохлов А. Л., Лисенкова Л. А., Раков А. А. Анализ факторов, определяющих приверженность к антигипертензивной терапии. Качественная клиническая практика 2003; (4): 59-66).
15. AB E, Denig P, van Vliet T, Dekker J. Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study. BMC Fam Pract 2009 21; 10: 24.
16. Caulina EM, Didur MD. The problem of low adherence of physicians outpatient practices to undertake comprehensive rehabilitation of patients with arterial hypertension. Scientific notes of Saint-Petersburg state medical University n.a. Acad. I. P. Pavlov, 2009; 1: 65 p. Russian (Каулина Е. М., Дидур М. Д. Проблема низкой приверженности врачей амбулаторной практики к проведению комплексных реабилитационных мероприятий у больных артериальной гипертонией. Ученые записки Санкт-Петербургского государственного медицинского университета имени акад. И. П. Павлова 2009; 1: 65 c).
17. Improving physician adherence to clinical practice guidelines. Barriers and strategies for change. New England Healthcare Institute 2008; 55 pp.